Stay updated with breaking news from Burrillb crohn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The analysis demonstrates clinical remission in 52.5% (n=114) of 217 moderate to severe ulcerative colitis (UC) patients (intent-to-treat population, ITT) after two years (96 weeks) of once-daily oral ....
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2b QUASAR Induction Study 1 in adults with. ....